Unknown

Dataset Information

0

Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe.


ABSTRACT: Epithelial ovarian cancer (EOC) is the seventh most common cancer among women worldwide. The 5-year survival rate for women with EOC is only 30%-50%, which is largely due to the typically late diagnosis of this condition. EOC is difficult to detect in its early stage because of its asymptomatic nature. Recently, near-infrared fluorescent (NIRF) imaging has been developed as a potential tool for detecting EOC at the molecular level. In this study, a NIRF-sensitive probe was designed to detect matrix metalloproteinase (MMP) activity in ovarian cancer cells. A cyanine fluorochrome was conjugated to the amino terminus of a peptide substrate with enzymatic specificity for MMP-3. To analyze the novel MMP-3 probe, an in vivo EOC model was established by subcutaneously implanting SKOV3 cells, a serous-type EOC cell line, in mice. This novel MMP-3-sensitive probe specifically reacted with only the active MMP-3 enzyme, resulting in a significantly enhanced NIRF emission intensity. Histological analysis demonstrated that MMP-3 expression and activity were enhanced in the stromal cells surrounding the ovarian cancer cells. These studies establish a molecular imaging reporter for diagnosing early-stage EOC. Additional studies are required to confirm the early-stage activity of MMP-3 in EOC and its diagnostic and prognostic significance.

SUBMITTER: Wang KH 

PROVIDER: S-EPMC5794152 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe.

Wang Kuo-Hwa KH   Wang Yun-Ming YM   Chiu Li-Hsuan LH   Chen Tze-Chien TC   Tsai Yu-Hui YH   Zuo Chun S CS   Chen Kuan-Chou KC   Changou Chun Austin CA   Lai Wen-Fu T WT  

PloS one 20180201 2


Epithelial ovarian cancer (EOC) is the seventh most common cancer among women worldwide. The 5-year survival rate for women with EOC is only 30%-50%, which is largely due to the typically late diagnosis of this condition. EOC is difficult to detect in its early stage because of its asymptomatic nature. Recently, near-infrared fluorescent (NIRF) imaging has been developed as a potential tool for detecting EOC at the molecular level. In this study, a NIRF-sensitive probe was designed to detect mat  ...[more]

Similar Datasets

| S-EPMC2531239 | biostudies-literature
| S-EPMC4177906 | biostudies-literature
| S-EPMC3608398 | biostudies-literature
| S-EPMC2912453 | biostudies-literature
| S-EPMC7137188 | biostudies-literature
| S-EPMC4317866 | biostudies-other
| S-EPMC4705538 | biostudies-literature
| S-EPMC6162053 | biostudies-literature
| S-EPMC6358871 | biostudies-literature
| S-EPMC3423536 | biostudies-literature